JDRF is the leading non-for-profit supporter of type 1 diabetes research globally, investing over AUD $100 million into Australian research since 1984.
Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat type one diabetes and its complications.
JDRF’s vision is of a world without type 1 diabetes, just as we have largely stamped out debilitating diseases like polio and smallpox. This is not a vision based on hope alone. JDRF-funded research is actively driving the creation of this future. We know it is possible, we just can’t say exactly when. However, we know we can get there faster with a strategic plan rooted in science and executed by applying the same rigorous performance standards used in for-profit businesses to the type 1 diabetes research field.
The essence of JDRF’s strategic plan is to drive and support the development and delivery to patients of an ongoing stream of therapies and devices that lessen the impact of type 1 diabetes – keeping people with type 1 diabetes healthy and safe now, until a cure is available.
JDRF is actively working to translate discoveries into therapies that reach those living with type 1 diabetes. As a result, JDRF today is the only type 1 diabetes research organisation in the public or private sector that allocates resources across the entire scientific spectrum, from discovery in the laboratory to delivery of new technology and treatments for people with type 1 diabetes. This is the basis for a multiyear strategic plan, with explicit milestones, to deliver on our commitment to patients, donors, partners, and the type 1 diabetes community.
Type 1 diabetes currently affects over 120,000 people in Australia and accounts for nearly AUD $1.6 billion a year in Australian healthcare costs. JDRF’s commitment to creating a world without type 1 diabetes drives our comprehensive global strategies to reduce the impact of type 1 diabetes in the lives of those affected by the disease.
By focusing on the delivery of increasingly effective therapies, JDRF will progressively remove the daily disease burden and lessen the risk of premature death and long-term complications as we work toward the ultimate goal of removing type 1 diabetes from our lives forever.